This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

​Auden Mckenzie, Advanz Pharma, others overturn UK CMA fines over hydrocortisone market behavior

By Simon Zekaria ( March 8, 2024, 14:47 GMT | Insight) -- Auden Mckenzie, Advanz Pharma and other drugmakers have overturned fines imposed by the UK Competition and Markets Authority over their behavior in the market for hydrocortisone tablets. In a ruling today, the Competition Appeal Tribunal said its earlier provisional verdict — which upheld the CMA’s findings over cartel infringements — could no longer stand, because it found errors in the way the authority’s lawyers had cross-examined witnesses in trial.Auden Mckenzie, Advanz Pharma and other drugmakers have overturned fines imposed by the UK Competition and Markets Authority over their behavior in the market for hydrocortisone tablets, following a ruling today from the Competition Appeal Tribunal....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections